Cell Therapy
Total Trials
6
As Lead Sponsor
As Collaborator
0
Total Enrollment
396
NCT05011370
Prevalence of Liver Disease in Patients Dependent on Parenteral Nutrition
Phase: N/A
Role: Lead Sponsor
Start: Aug 23, 2021
Completion: Jun 29, 2023
NCT05085977
Safety and Toxicity Study of Intravesical Instillation of TARA-002 in Adults with High-grade Non-muscle Invasive Bladder Cancer (Phase 1a)
Phase: Phase 1
Start: Mar 10, 2022
Completion: Oct 30, 2024
NCT05085990
Safety and Toxicity Study of Intravesical Instillation of TARA-002 in Adults with High-grade Non-muscle Invasive Bladder Cancer (Phase 1b)
Start: May 8, 2023
Completion: Sep 12, 2024
NCT05951179
Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer
Phase: Phase 2
Start: Sep 15, 2023
Completion: Aug 31, 2030
NCT05871970
Safety and Efficacy Study of Intracystic TARA-002 for the Treatment of Lymphatic Malformations in Participants 6 Months to Less Than 18 Years of Age
Start: Oct 18, 2023
Completion: May 31, 2026
NCT06910943
Study of Choline Chloride for Injection in Adolescent and Adult Patients With Intestinal Failure Receiving Long Term Parenteral Support
Phase: Phase 2/3
Start: Sep 30, 2025
Completion: Jun 30, 2028
Loading map...